Jefferies Financial Group Weighs in on ADIDAS AG/S’s FY2019 Earnings (OTCMKTS:ADDYY)

Share on StockTwits

ADIDAS AG/S (OTCMKTS:ADDYY) – Investment analysts at Jefferies Financial Group issued their FY2019 earnings per share estimates for shares of ADIDAS AG/S in a research note issued to investors on Monday, December 2nd. Jefferies Financial Group analyst J. Grzinic anticipates that the company will earn $5.41 per share for the year. Jefferies Financial Group has a “Hold” rating on the stock. Jefferies Financial Group also issued estimates for ADIDAS AG/S’s FY2020 earnings at $6.14 EPS and FY2021 earnings at $6.80 EPS.

A number of other research analysts also recently issued reports on ADDYY. Societe Generale upgraded ADIDAS AG/S from a “hold” rating to a “buy” rating in a report on Monday, November 18th. Zacks Investment Research cut ADIDAS AG/S from a “hold” rating to a “sell” rating in a report on Monday, October 21st. Sanford C. Bernstein began coverage on ADIDAS AG/S in a research report on Friday, September 20th. They issued a “market perform” rating on the stock. Piper Jaffray Companies cut ADIDAS AG/S from an “overweight” rating to a “neutral” rating in a research note on Monday, October 21st. Finally, ValuEngine raised ADIDAS AG/S from a “sell” rating to a “hold” rating in a research note on Friday, November 8th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the company’s stock. ADIDAS AG/S presently has a consensus rating of “Hold” and a consensus price target of $154.00.

ADIDAS AG/S stock opened at $155.04 on Wednesday. The company has a current ratio of 1.37, a quick ratio of 0.91 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average of $153.18 and a 200-day moving average of $151.36. The firm has a market cap of $62.16 billion, a P/E ratio of 31.32, a P/E/G ratio of 1.96 and a beta of 0.74. ADIDAS AG/S has a 1-year low of $101.48 and a 1-year high of $165.01.

ADIDAS AG/S (OTCMKTS:ADDYY) last announced its quarterly earnings results on Wednesday, November 6th. The company reported $1.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.77 by $0.04. ADIDAS AG/S had a net margin of 8.27% and a return on equity of 26.81%. The business had revenue of $7.13 billion for the quarter, compared to analyst estimates of $7.02 billion.

Institutional investors have recently made changes to their positions in the business. Parametric Portfolio Associates LLC grew its position in shares of ADIDAS AG/S by 3.9% in the 3rd quarter. Parametric Portfolio Associates LLC now owns 408,101 shares of the company’s stock worth $63,541,000 after buying an additional 15,138 shares during the period. Public Employees Retirement System of Ohio purchased a new position in ADIDAS AG/S during the 3rd quarter valued at about $2,085,000. First Mercantile Trust Co. purchased a new position in ADIDAS AG/S during the 3rd quarter valued at about $912,000. MAI Capital Management bought a new stake in ADIDAS AG/S during the second quarter worth about $648,000. Finally, OLD National Bancorp IN bought a new stake in ADIDAS AG/S during the third quarter worth about $356,000. 0.14% of the stock is owned by institutional investors and hedge funds.

About ADIDAS AG/S

adidas AG, together with its subsidiaries, designs, develops, produces, and markets athletic and sports lifestyle products worldwide. The company operates in 10 segments: Europe, North America Adidas, North America Reebok, Asia-Pacific, Latin America, Emerging Markets, Russia/CIS, Adidas Golf, Runtastic, and Other Centrally Managed Businesses.

Recommended Story: What is the Euro STOXX 50 Index?

Earnings History and Estimates for ADIDAS AG/S (OTCMKTS:ADDYY)

Receive News & Ratings for ADIDAS AG/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADIDAS AG/S and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.